ES3059573T3 - Methods of detecting isoaspartic acid - Google Patents

Methods of detecting isoaspartic acid

Info

Publication number
ES3059573T3
ES3059573T3 ES21807318T ES21807318T ES3059573T3 ES 3059573 T3 ES3059573 T3 ES 3059573T3 ES 21807318 T ES21807318 T ES 21807318T ES 21807318 T ES21807318 T ES 21807318T ES 3059573 T3 ES3059573 T3 ES 3059573T3
Authority
ES
Spain
Prior art keywords
protein
isoasp
peptide
fragmentation
mass spectrometry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21807318T
Other languages
English (en)
Spanish (es)
Inventor
John On-Ting Hui
Iain David Grant Campuzano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ES3059573T3 publication Critical patent/ES3059573T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES21807318T 2020-10-01 2021-09-30 Methods of detecting isoaspartic acid Active ES3059573T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063086557P 2020-10-01 2020-10-01
US202163218186P 2021-07-02 2021-07-02
PCT/US2021/052783 WO2022072583A1 (en) 2020-10-01 2021-09-30 Methods of detecting isoaspartic acid

Publications (1)

Publication Number Publication Date
ES3059573T3 true ES3059573T3 (en) 2026-03-23

Family

ID=78621972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21807318T Active ES3059573T3 (en) 2020-10-01 2021-09-30 Methods of detecting isoaspartic acid

Country Status (10)

Country Link
US (1) US20230366889A1 (https=)
EP (1) EP4222500B1 (https=)
JP (1) JP2023546796A (https=)
CN (1) CN116348770A (https=)
AU (1) AU2021351498A1 (https=)
CA (1) CA3196920A1 (https=)
ES (1) ES3059573T3 (https=)
MX (1) MX2023003862A (https=)
TW (1) TWI907533B (https=)
WO (1) WO2022072583A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114144668B (zh) * 2019-07-17 2025-02-11 株式会社岛津制作所 异天冬氨酸的分析方法和质谱分析装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190073452A1 (en) * 2015-09-25 2019-03-07 Bioanalytix, Inc. Method for determining the in vivo comparability of a biologic drug and a reference drug
JP6665740B2 (ja) * 2016-09-13 2020-03-13 株式会社島津製作所 ペプチド解析方法、ペプチド解析装置、及びペプチド解析用プログラム
CN110779979A (zh) * 2019-10-09 2020-02-11 南昌大学 一种基于寡糖异构体组成差异鉴别蜂蜜糖浆掺假的方法

Also Published As

Publication number Publication date
EP4222500B1 (en) 2025-11-12
WO2022072583A1 (en) 2022-04-07
TWI907533B (zh) 2025-12-11
MX2023003862A (es) 2023-04-14
AU2021351498A1 (en) 2023-05-04
EP4222500C0 (en) 2025-11-12
CA3196920A1 (en) 2022-04-07
CN116348770A (zh) 2023-06-27
EP4222500A1 (en) 2023-08-09
TW202223377A (zh) 2022-06-16
JP2023546796A (ja) 2023-11-08
AU2021351498A9 (en) 2025-03-27
US20230366889A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
Hao et al. Recent advances in mass spectrometric analysis of protein deamidation
Damen et al. Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab
Jansson Strategies for analysis of isomeric peptides
Riggs et al. Sequence and solution effects on the prevalence of d-isomers produced by deamidation
Wang et al. Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry
US9181326B2 (en) Analysis of ubiquitinated polypeptides
Sohn et al. Click chemistry facilitates formation of reporter ions and simplified synthesis of amine-reactive multiplexed isobaric tags for protein quantification
CN102762987B (zh) 测定多肽的序列变体的方法
JP2013507603A (ja) 署名ペプチドおよび質量分析による混合物中の個々の組換えタンパク質の多重定量化
WO2015120036A1 (en) Compositions and methods for analysis of protein sequences and post-translational modifications
US20090317409A1 (en) Antibodies for ubiquitinated proteins
Liu et al. Quantitation of asparagine deamidation by isotope labeling and liquid chromatography coupled with mass spectrometry analysis
ES3059573T3 (en) Methods of detecting isoaspartic acid
US11352418B2 (en) Analysis of ubiquitinated polypeptides
Russo et al. Ultra‐performance liquid chromatography/multiple reaction monitoring mass spectrometry quantification of trastuzumab in human serum by selective monitoring of a specific peptide marker from the antibody complementarity‐determining regions
Fornelli et al. Structural analysis of monoclonal antibodies with top-down and middle-down electron transfer dissociation mass spectrometry: the first decade
Ren et al. Top-down N-terminal sequencing of Immunoglobulin subunits with electrospray ionization time of flight mass spectrometry
Wu et al. Localizing Isomerized Residue Sites in Peptides with Tandem Mass Spectrometry
Klapoetke et al. Disulfide bond characterization of human factor Xa by mass spectrometry through protein-level partial reduction
US20240053359A1 (en) Native microfluidic ce-ms analysis of antibody charge heterogeneity
Sousa et al. Primary sequence determination of a monoclonal antibody against α-synuclein using a novel mass spectrometry-based approach
US20220011318A1 (en) Heavy peptide approach to accurately measure unprocessed c-terminal lysine in antibodies
KR20170071849A (ko) Lc-ms를 이용하는 항체 약물의 혈액 내 정량방법
Hessmann Development of analytical strategies in quantitative proteomic: quantitation of host cell proteins by mass spectrometry as a quality control tool for the biopharmaceutical industry
Mena Pérez Pharmacokinetics and Metabolism: Analysis of Low-abundant Deamidation and Oxidation Modifications in Therapeutic Species in Complex Biological Matrices by Liquid Chromatographic and Mass Spectrometry Methods